Ternacle, J., Krapf, L., Mohty, D., et al. Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74 (2019), 2638–2651.
Nitsche, C., Scully, P.R., Patel, K.P., et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 77 (2021), 128–139.
Scully, P.R., Patel, K.P., Treibel, T.A., et al. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J 41 (2020), 2759–2767.
Castaño, A., Narotsky, D.L., Hamid, N., et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38 (2017), 2879–2887.
Cavalcante, J.L., Rijal, S., Abdelkarim, I., et al. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J Cardiovasc Magn Reson, 19, 2017, 98.
Treibel, T.A., Fontana, M., Gilbertson, J.A., et al. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging, 9, 2016, e005066.
Kristen, A.V., Schnabel, P.A., Winter, B., et al. High prevalence of amyloid in 150 surgically removed heart valves–a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol 19 (2010), 228–235.
Audet, A., Côté, N., Couture, C., et al. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology 61 (2012), 610–619.
Tastet, L., Tribouilloy, C., Maréchaux, S., et al. Staging cardiac damage in patients with asymptomatic aortic valve stenosis. J Am Coll Cardiol 74 (2019), 550–563.
Pibarot, P., Salaun, E., Dahou, A., et al. Echocardiographic results of transcatheter versus surgical aortic valve replacement in low-risk patients: the PARTNER 3 trial. Circulation 141 (2020), 1527–1537.
Cremer, P.C., Zhang, Y., Alu, M., et al. The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA. Eur Heart J 39 (2018), 2659–2667.
